Home » Reports » Broker Ratings » AstraZeneca plc 16.3% Potential Upside Indicated by Jefferies International
broker ratings

AstraZeneca plc 16.3% Potential Upside Indicated by Jefferies International

AstraZeneca plc with EPIC/TICKER (LON:AZN) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ today by analysts at Jefferies International. AstraZeneca plc are listed in the Health Care sector within UK Main Market. Jefferies International have set a target price of 6050 GBX on its stock. This would indicate that the analyst believes there is a potential upside of 16.3% from the opening price of 5203 GBX. Over the last 30 and 90 trading days the company share price has decreased 156 points and increased 182 points respectively. The 52 week high share price is 5523 GBX while the year low stock price is currently 4260 GBX.

AstraZeneca plc has a 50 day moving average of 5,354.58 GBX and the 200 Day Moving Average price is recorded at 5,070.64. There are currently 1,266,663,808 shares in issue with the average daily volume traded being 2,240,854. Market capitalisation for LON:AZN is £67,336,366,750 GBP.